167. マルファン症候群 Marfan syndrome Clinical trials / Disease details

臨床試験数 : 21 / 薬物数 : 40 - (DrugBank : 11) / 標的遺伝子数 : 10 - 標的パスウェイ数 : 50

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2008-001462-81-IT (EUCTR)	27/10/2008	17/03/2008	Effects of Losartan versus Nebivololversus the association of both on the progression of aortic root ...	Effects of Losartan versus Nebivololversus the association of both on the progression of aortic root ...	Marfan Syndrome MedDRA version: 9.1;Level: LLT;Classification code 10026829;Term: Marfan's syndrome	Trade Name: LORTAAN 28CPR RIV DIV 50MG INN or Proposed INN: Losartan Trade Name: LOBIVON 28CPR 5MG INN ...	OSPEDALE POLICLINICO S. MATTEO	NULL	Not Recruiting			Female: yes Male: yes		Phase 3	Italy
2	NCT00683124 (ClinicalTrials.gov)	July 2008	21/5/2008	NebivololVersus Losartan Versus Nebivolol+Losartan Against Aortic Root Dilation in Genotyped Marfan ...	Effects of Losartan vs. Nebivololvs. the Association of Both on the Progression of Aortic Root Dilat ...	Marfan Syndrome	Drug: Losartan and nebivolol;Drug: Losartan;Drug: Nebivolol	IRCCS Policlinico S. Matteo	Merck Sharp & Dohme Corp.;Menarini Group	Recruiting	12 Months	55 Years	Both	291	Phase 3	Italy

First Previous1Next Last